Robert R, Rouffineau J, Cremault A, Bauple J L, Pourrat O, Gil R, Patte D
Presse Med. 1984 Sep 22;13(32):1947-9.
Intrathecal serotherapy appears to be effective in the treatment of tetanus, and it has been claimed that human immune globulins are innocuous. In the 4 cases reported here reversible paraplegia developed a few hours after intrathecal injection of 1500 to 2000 UI of human immune globulins prepared by the French Blood Transfusion Centre. We believe that paraplegia was related to the high doses administered. The fact that intrathecal serotherapy is normally used in severely ill patients whose impaired consciousness precludes motricity and sensitivity testing may explain why this complication has not previously been reported. The need for high doses of intrathecal immune globulins is discussed. It has recently been suggested that high doses are superior to low doses. We consider that this form of treatment is justified, even in the least severe forms of tetanus, but we feel that doses higher than 1000 IU are not without danger.
鞘内血清疗法在破伤风治疗中似乎有效,并且据称人免疫球蛋白是无害的。在此报告的4例病例中,鞘内注射法国输血中心制备的1500至2000国际单位人免疫球蛋白后数小时出现了可逆性截瘫。我们认为截瘫与所给予的高剂量有关。鞘内血清疗法通常用于病情严重、意识受损而无法进行运动和感觉测试的患者,这一事实或许可以解释为何此前未报告过这种并发症。文中讨论了鞘内注射高剂量免疫球蛋白的必要性。最近有人提出高剂量优于低剂量。我们认为即使是最轻微的破伤风形式,这种治疗方式也是合理的,但我们觉得剂量超过1000国际单位并非没有危险。